Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2026-01-05 @ 5:28 PM
Study NCT ID:
NCT03139903
Status:
COMPLETED
Last Update Posted:
2017-11-20
First Post:
2017-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'C565898', 'term': 'Microcephalic Osteodysplastic Primordial Dwarfism, Type II'}, {'id': 'C537533', 'term': 'Seckel syndrome 1'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'FAMILY_BASED'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 30}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2010-07-28', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-11', 'completionDateStruct': {'date': '2015-07', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-11-17', 'studyFirstSubmitDate': '2017-03-23', 'studyFirstSubmitQcDate': '2017-05-02', 'lastUpdatePostDateStruct': {'date': '2017-11-20', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2017-05-04', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2013-07-16', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'to visualize any vascular abnormalities according the cerebral angiography-MRI', 'timeFrame': '10 months'}], 'secondaryOutcomes': [{'measure': 'Assessment of intelligence and cognitive ability according the Wechsler Intelligence Scale for Children (WISC-IV)', 'timeFrame': '2 days'}, {'measure': 'Measurement of visual acuity', 'timeFrame': '2 days'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Seckel Syndrome', 'Microcephalic Osteodysplastic Primordial Dwarfism Type II'], 'conditions': ['Microcephalic Osteodysplastic Primordial Dwarfism Type II', 'Seckel Syndrome']}, 'descriptionModule': {'briefSummary': 'The purpose of this study si to define morphological and epidemiological parameters and identify new symptoms in French patients with Seckel syndrome (SCKL) or microcephalic osteodysplastic primordial dwarfism type II (MOPDII).', 'detailedDescription': 'Multicentre study, aiming to determine morphological and epidemiological parameters and identify new symptoms in French patients with SCKL or MOPDII.\n\nAt pre-inclusion visit: Realization of the photographs of: the face, entire body and the extremities (hands and feet) that will be serve for the collegiate decision of the inclusion or not of patients.\n\nPatients are seen at inclusion V1 , a second visit V2 at 6-10 months after V1 and an annual follow-up visit.\n\nAt inclusion:\n\n* Full Clinical Examination, specialized consultations (Otorhinolaryngology, stomatology, orthopedics, ophthalmology)\n* Results of x-ray examinations and biological tests\n* Assessment of the patients competencies and initiation of appropriate care ( orthophony and psychomotricity...)\n* Assessment of intelligence and cognitive ability according the WISC-IV scale\n* Blood testing for diagnosis and research.\n\nVisit 2:\n\n* Full Clinical Examination\n* Cerebral angiography-MRI for all patients\n* Programming a neurosurgery / neurovascular consultation based on MRI results\n* Immuno-hematology and hepato-gastroenterology consultation if anomaly during the visit V1\n\nAnnual follow-up visit:\n\n* Assessment of the complications of the disease and its clinical care\n* Full clinical examination\n* Skeletal x-ray and systematic orthopedic consultation\n* Blood Check\n* Prescription of tests if necessary depending to the complications identified of the disease\n* Reevaluation of the care according to the detected symptoms'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '2 Months', 'samplingMethod': 'PROBABILITY_SAMPLE', 'studyPopulation': 'Patients with Primordial Dwarfisms have been followed by network geneticists for which there is no systematic and homogeneous collection of biological, radiological and clinical data', 'healthyVolunteers': True, 'eligibilityCriteria': "Inclusion Criteria:\n\nPatients aged from 2 months to 50 years must present all of the following criteria:\n\n* Symmetrical intrauterine growth restriction (IUGR) \\< - 2 DS, Birth size \\<-2 DS and Cranial perimeter of birth \\<-2 DS\n* Postnatal growth restriction (size \\<-4DS)\n* Microcephaly \\<-4DS\n* Clinical Diagnosis of Seckel Syndrome or Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) by a geneticist\n* Having given free and informed consent\n\nExclusion Criteria:\n\n* Refutation of the diagnosis\n* Parents' refusal to participate in genetic studies once the diagnosis of SCKL or MOPDII has been establish for the patient (major or minor)\n* Allergy to gadolinium, contraindicating the realization of an Angio-MRI\n* Absence of affiliation to a social security scheme or Universal Health Coverage."}, 'identificationModule': {'nctId': 'NCT03139903', 'acronym': 'NANPIM', 'briefTitle': 'The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II', 'organization': {'class': 'OTHER', 'fullName': 'Assistance Publique - Hôpitaux de Paris'}, 'officialTitle': 'The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II (MOPDII).', 'orgStudyIdInfo': {'id': 'P081256'}}, 'contactsLocationsModule': {'locations': [{'zip': '75743', 'city': 'Paris', 'country': 'France', 'facility': 'Medical Genetics Department and INSERM U781, Necker-Enfants Malades Hospital', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}], 'overallOfficials': [{'name': 'CORMIER-DAIRE Valérie, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Medical Genetics Department and INSERM U781, Necker-Enfants Malades Hospital, 75743 Paris, France'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Assistance Publique - Hôpitaux de Paris', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}